Matarin Capital Management’s Emergent Biosolutions EBS Stock Holding History

Matarin Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$1.71M	Sell	19,133 -11,350	-37%	-$1.02M	0.42%	114
2020 Q3	$3.15M	Sell	30,483 -54,310	-64%	-$5.61M	0.66%	67
2020 Q2	$6.71M	Sell	84,793 -14,177	-14%	-$1.12M	1.34%	5
2020 Q1	$5.73M	Buy	+98,970	New	+$5.73M	0.89%	24
2019 Q3	–	Sell	-143,509	Closed	-$6.93M	–	255
2019 Q2	$6.93M	Sell	143,509 -227,204	-61%	-$11M	0.5%	82
2019 Q1	$18.7M	Sell	370,713 -827	-0.2%	-$41.8K	1.36%	2
2018 Q4	$22M	Sell	371,540 -1,440	-0.4%	-$85.4K	1.78%	1
2018 Q3	$24.6M	Buy	372,980 +33,181	+10%	+$2.18M	1.58%	2
2018 Q2	$17.2M	Sell	339,799 -12,031	-3%	-$607K	1.24%	5
2018 Q1	$18.5M	Buy	351,830 +26,919	+8%	+$1.42M	1.39%	4
2017 Q4	$15.1M	Buy	324,911 +14,705	+5%	+$683K	1.18%	7
2017 Q3	$12.5M	Buy	310,206 +47,465	+18%	+$1.92M	1.07%	11
2017 Q2	$8.91M	Buy	262,741 +5,075	+2%	+$172K	0.82%	32
2017 Q1	$7.48M	Buy	257,666 +29,979	+13%	+$871K	0.74%	44
2016 Q4	$7.48M	Buy	227,687 +8,053	+4%	+$264K	0.84%	31
2016 Q3	$6.93M	Buy	219,634 +9,830	+5%	+$310K	0.76%	39
2016 Q2	$5.9M	Buy	209,804 +287	+0.1%	+$8.07K	0.8%	38
2016 Q1	$7.62M	Buy	209,517 +10,737	+5%	+$390K	1.06%	13
2015 Q4	$7.95M	Buy	198,780 +23,391	+13%	+$936K	1.19%	8
2015 Q3	$5M	Buy	175,389 +73,545	+72%	+$2.1M	1.02%	25
2015 Q2	$3.36M	Buy	101,844 +26,464	+35%	+$872K	0.96%	23
2015 Q1	$2.17M	Sell	75,380 -7,172	-9%	-$206K	0.66%	65
2014 Q4	$2.25M	Sell	82,552 -2,451	-3%	-$66.7K	0.99%	27
2014 Q3	$1.81M	Sell	85,003 -743	-0.9%	-$15.8K	0.83%	44
2014 Q2	$1.93M	Buy	85,746 +14,630	+21%	+$329K	0.86%	45
2014 Q1	$1.8M	Sell	71,116 -5,421	-7%	-$137K	1.06%	22
2013 Q4	$1.76M	Buy	76,537 +36,071	+89%	+$829K	1.08%	40
2013 Q3	$771K	Buy	40,466 +5,567	+16%	+$106K	0.65%	68
2013 Q2	$503K	Buy	+34,899	New	+$503K	0.51%	80